Organization
Institute of Medical Science, University of Toronta
1 abstract
Abstract
ASSESSMENT OF PAIN OUTCOMES IN A PHASE 2 TRIAL OF DEUCRAVACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITISOrg: Bristol Myers Squibb, Stanford University School of Medicine, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Rheumatology, Seattle, United States of America, University of Washington School of Medicine, Institute of Medical Science, University of Toronta,